Quarterly report pursuant to Section 13 or 15(d)

Common Stock (Details Narrative)

v3.10.0.1
Common Stock (Details Narrative) - USD ($)
3 Months Ended 9 Months Ended
Jan. 05, 2018
Feb. 28, 2017
Sep. 30, 2018
Mar. 31, 2018
Sep. 30, 2017
Sep. 30, 2018
Sep. 30, 2017
Dec. 31, 2017
Common stock, shares authorized     150,000,000     150,000,000   150,000,000
Common stock, par value     $ 0.0001     $ 0.0001   $ 0.0001
Common stock, shares issued     57,237,496     57,237,496   55,603,427
Common stock, shares outstanding     57,237,496     57,237,496   55,603,427
Issuance of common stock upon exercise of stock options, shares     40,000   2,500 129,069 239,817  
Proceeds from exercise of stock options     $ 34,378   $ 8,250 $ 337,645 $ 109,053  
Proceeds from sale of stock           12,042,645 $ 41,378,762  
Stock issuance cost           $ 464,680    
January 2018 Sales Agreement [Member] | Institutional Investor [Member]                
Aggregate common stock sold, shares     1,500,000        
Proceeds from sale of stock     $ 11,200,000        
Sales Agreement [Member]                
Aggregate common stock sold, shares             1,413,633  
Proceeds from sale of stock             $ 13,268,208  
Securities Purchase Agreement [Member] | Institutional and Accredited Investors [Member]                
Aggregate common stock sold, shares   3,887,815            
Proceeds from sale of stock   $ 27,214,705            
Purchase price per share   $ 7.00            
Stock issuance cost   $ 36,291            
At the Market Offering [Member] | Maximum [Member]                
Number of common stock value sold $ 50,000,000